Abstract
Background: Mucus protects the epithelium against invaders and toxic materials. Sticky and thick mucus is characteristic of CF. Objective: The aim of this systematic review is to characterize the specific mucins secreted in the lung and intestinal tract of CF patients. Methods: A systematic literature search was conducted up to December 31, 2019. The following terms were used: “cystic fibrosis” AND “mucin.” Case-control studies comparing mucin expression in CF patients to healthy controls were included. Results: We found 741 eligible studies, 694 studies were rejected because they were performed in animals and not in full text, and 32 studies were excluded being editorials, duplications, review articles, meta-analysis, or not in English. Fifteen studies were eligible for our study, including 150 CF patients compared to 82 healthy controls, all fulfilled the inclusion criteria. The main mucin types expressed in the sinus submucosal glands, sputum, tracheobronchial surface epithelium, and lung submucosal glands were MUC5AC and MUC5B. Increase in the number of sinusoidal submucosal glands and expression of MUC5B was found in CF patients, but no such difference from healthy controls was found for the number of goblet cells in the surface epithelium nor in the expression of -MUC5AC. The opposite was found in the tracheobronchial surface epithelium and in the lungs. Conclusions: Increased expression of MUC5AC in the surface epithelium and of MUC5B in the subepithelial glands may be the result of higher secretion rate of mucin into the lumen of the respiratory tract, causing mucus plaque, infection, and inflammation.
References
1.
Senapati
S
, Das
S
, Batra
SK
. Mucin-interacting proteins: from function to therapeutics
. Trends Biochem Sci
. 2010
;35
(4
):236
–45
. .2.
Corfield
AP
, Myerscough
N
, Longman
R
, Sylvester
P
, Arul
S
, Pignatelli
M
. Mucins and mucosal protection in the gastrointestinal tract: new prospects for mucins in the pathology of gastrointestinal disease
. Gut
. 2000
;47
(4
):589
–94
. .3.
Sarosiek
J
, McCallum
RW
. What is the secretory potential of submucosal mucous glands within the human gullet in health and disease?
Digestion
. 1995
;56
(Suppl 1
):15
–23
. .4.
Kreda
SM
, Davis
CW
, Rose
MC
. CFTR, mucins, and mucus obstruction in cystic fibrosis
. Cold Spring Harb Perspect Med
. 2012
;2
(9
):a009589
–32
. .5.
Ehre
C
, Ridley
C
, Thornton
DJ
. Cystic fibrosis: an inherited disease affecting mucin-producing organs
. Int J Biochem Cell Biol
. 2014
;52
:136
–45
. .6.
Henke
MO
, Renner
A
, Huber
RM
, Seeds
MC
, Rubin
BK
. MUC5AC and MUC5B mucins are decreased in cystic fibrosis airway secretions
. Am J Respir Cell Mol Biol
. 2004
;31
(1
):86
–91
. .7.
Kirkham
S
, Sheehan
JK
, Knight
D
, Richardson
PS
, Thornton
DJ
. Heterogeneity of airways mucus: variations in the amounts and glycoforms of the major oligomeric mucins MUC5AC and MUC5B
. Biochem J
. 2002
;361
(Pt 3
):537
–46
. .8.
Montserrat
C
, Merten
M
, Figarella
C
. Defective ATP-dependent mucin secretion by cystic fibrosis pancreatic epithelial cells
. FEBS Lett
. 1996
;393
(2–3
):264
–8
. .9.
Wesley
A
, Forstner
J
, Qureshi
R
, Mantle
M
, Forstner
G
. Human intestinal mucin in cystic fibrosis
. Pediatr Res
. 1983
;17
(1
):65
–9
. .10.
Rose
MC
, Brown
CF
, Jacoby
JZ
, Lynn
WS
, Kaufman
B
. Biochemical properties of tracheobronchial mucins from cystic fibrosis and non-cystic fibrosis individuals
. Pediatr Res
. 1987
;22
(5
):545
–51
. .11.
Gupta
R
, Jentoft
N
. The structure of tracheobronchial mucins from cystic fibrosis and control patients
. J Biol Chem
. 1992
;267
(5
):3160
–7
. .12.
Li
D
, Wang
D
, Majumdar
S
, Jany
B
, Durham
SR
, Cottrell
J
, et al. Localization and up-regulation of mucin (MUC2) gene expression in human nasal biopsies of patients with cystic fibrosis
. J Pathol
. 1997
;181
(3
):305
–10
. .13.
Reid
CJ
, Hyde
K
, Ho
SB
, Harris
A
. Cystic fibrosis of the pancreas: involvement of MUC6 mucin in obstruction of pancreatic ducts
. Mol Med
. 1997
;3
(6
):403
–11
.14.
Harris
A
, Reid
C
. Cystic fibrosis and mucins
. J Med Genet
. 1998
;35
(1
):82
–3
. .15.
Voynow
JA
, Selby
DM
, Rose
MC
. Mucin gene expression (MUC1, MUC2, and MUC5/5AC) in nasal epithelial cells of cystic fibrosis, allergic rhinitis, and normal controls
. Lung
. 1998
;176
:345
–54
.16.
Davies
JR
, Svitacheva
N
, Lannefors
L
, Kornfält
R
, Carlstedt
I
. Identification of MUC5B, MUC5AC and small amounts of MUC2 mucins in cystic fibrosis airway secretions
. Biochem J
. 1999
;344
(Pt 2
):321
–30
. .17.
Groneberg
DA
, Eynott
PR
, Oates
T
, Lim
S
, Wu
R
, Carlstedt
I
, et al. Expression of MUC5AC and MUC5B mucins in normal and cystic fibrosis lung
. Respir Med
. 2002
;96
(2
):81
–6
. .18.
Kirkham
S
, Sheehan
JK
, Knight
D
, Richardson
PS
, Thornton
DJ
. Heterogeneity of airways mucus: variations in the amounts and glycoforms of the major oligomeric mucins MUC5AC and MUC5B
. Biochem J
. 2002
;361
(Pt 3
):537
–46
. .19.
Schulz
BL
, Sloane
AJ
, Robinson
LJ
, Sebastian
LT
, Glanville
AR
, Song
Y
, et al. Mucin glycosylation changes in cystic fibrosis lung disease are not manifest in submucosal gland secretions
. Biochem J
. 2005
;387
(Pt 3
):911
–9
. .20.
Henke
MO
, John
G
, Germann
M
, Lindemann
H
, Rubin
BK
. MUC5AC and MUC5B mucins increase in cystic fibrosis airway secretions during pulmonary exacerbation
. Am J Respir Crit Care Med
. 2007
;175
(8
):816
–21
. .21.
Guo
X
, Pace
RG
, Stonebraker
JR
, Commander
CW
, Dang
AT
, Drumm
ML
, et al. Mucin variable number tandem repeat polymorphisms and severity of cystic fibrosis lung disease: significant association with MUC5AC
. PLoS One
. 2011
;6
(10
):e25452
. .22.
Wu
X
, Amorn
MM
, Aujla
PK
, Rice
S
, Mimms
R
, Watson
AM
, et al. Histologic characteristics and mucin immunohistochemistry of cystic fibrosis sinus mucosa
. Arch Otolaryngol Head Neck Surg
. 2011
;137
(4
):383
–9
. .23.
Henderson
AG
, Ehre
C
, Button
B
, Abdullah
LH
, Cai
LH
, Leigh
MW
, et al. Cystic fibrosis airway secretions exhibit mucin hyperconcentration and increased osmotic pressure
. J Clin Invest
. 2014
;124
(7
):3047
–60
. .24.
Garcia
MA
, Yang
N
, Quinton
PM
. Normal mouse intestinal mucus release requires cystic fibrosis transmembrane regulator-dependent bicarbonate secretion
. J Clin Invest
. 2009
;119
(9
):2613
–22
. .25.
Caramori
G
, Di Gregorio
C
, Carlstedt
I
, Casolari
P
, Guzzinati
I
, Adcock
IM
, et al. Mucin expression in peripheral airways of patients with chronic obstructive pulmonary disease
. Histopathology
. 2004
;45
(5
):477
–84
. .26.
Thomsson
KA
, Hansson
GC
, Kunzelman
K
. Identification and quantification of mucin expression
. In: Amaral
MD
, Kunzelman
K
, editors. Cystic fibrosis, methods in molecular biology
; 2011
. p. 127
–41
.27.
Yvonne
JH
, LiPuma
JT
. The microbiome in cystic fibrosis
. Clin Chest Med
. 2016
;37
:59
–67
.28.
Scott
P
, Anderson
K
, Singhania
M
, Cormier
R
. Cystic fibrosis, CFTR, and colorectal cancer
. Int J Mol Sci
. 2020
;21
(8
):2891
–21
. .© 2020 S. Karger AG, Basel
2020
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
